The DOI matches its Crossref record; 178 of the 178 references it cites were found in a registry or an index.
Revisiting fibrosis in inflammatory bowel disease: the gut thickens
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
Epidemiology and Natural History of Inflammatory Bowel Diseases
Cosnes, J., Gower–Rousseau, C., Seksik, P., & Cortot, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.055 · Cited by 2,211
Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx008 · Cited by 1,910
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765
Dignass, A., Van Assche, G., Lindsay, J. O., Lémann, M., Söderholm, J., Colombel, J. F., Danese, S., D'Hoore, A., Gassull, M., Gomollón, F., et al. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.12.002 · Cited by 1,498
Self-citationPresence of modified fibroblasts in granulation tissue and their possible role in wound contraction
Gabbiani, G., Ryan, G. B., & Majno, G. (1971) · Experientia · doi:10.1007/bf02147594 · Cited by 1,485
Long-Term Evolution of Disease Behavior of Crohn's Disease
Cosnes, J., Cattan, S., Blain, A., Beaugerie, L., Carbonnel, F., Parc, R., & Gendre, J.-P. (2002) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200207000-00002 · Cited by 1,346
Reyfman, P. A., Walter, J. M., Joshi, N., Anekalla, K. R., McQuattie-Pimentel, A. C., Chiu, S., Fernandez, R., Akbarpour, M., Chen, C.-I., Ren, Z., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2410oc · Cited by 1,203
Growing Self-Organizing Mini-Guts from a Single Intestinal Stem Cell: Mechanism and Applications
Sato, T., & Clevers, H. (2013) · Science · doi:10.1126/science.1234852 · Cited by 1,170
Type 2 immunity in tissue repair and fibrosis
Gieseck, R. L., Wilson, M. S., & Wynn, T. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.90 · Cited by 1,055 · cited 1×
“IL-8 antagonist, CXCL8(3-72)K11R/ G31P coupled with probiotic exhibit variably enhanced therapeutic potential in ameliorating ulcerative colitis.”
BackgroundVan Assche, G., Dignass, A., Reinisch, W., van der Woude, C. J., Sturm, A., De Vos, M., Guslandi, M., Oldenburg, B., Dotan, I., Marteau, P., et al. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.09.009 · Cited by 894
Fichtner-Feigl, S., Strober, W., Kawakami, K., Puri, R. K., & Kitani, A. (2006) · Nature Medicine · doi:10.1038/nm1332 · Cited by 889
Beaugerie, L., Seksik, P., Nion–Larmurier, I., Gendre, J., & Cosnes, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.019 · Cited by 860
Course and prognosis of ulcerative colitis: Part III Complications
Edwards, F. C., & Truelove, S. C. (1964) · Gut · doi:10.1136/gut.5.1.1 · Cited by 687
Cosnes, J., Nion-Larmurier, I., Beaugerie, L., Afchain, P., Tiret, E., & Gendre, J.-P. (2005) · Gut · doi:10.1136/gut.2004.045294 · Cited by 657
Kugathasan, S., Denson, L. A., Walters, T. D., Kim, M.-O., Marigorta, U. M., Schirmer, M., Mondal, K., Liu, C., Griffiths, A., Noe, J. D., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30317-3 · Cited by 633
Microfluidic Organ-on-a-Chip Models of Human Intestine
Bein, A., Shin, W., Jalili-Firoozinezhad, S., Park, M. H., Sontheimer-Phelps, A., Tovaglieri, A., Chalkiadaki, A., Kim, H. J., & Ingber, D. E. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.12.010 · Cited by 625
Monticelli, L. A., Osborne, L. C., Noti, M., Tran, S. V., Zaiss, D. M. W., & Artis, D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509070112 · Cited by 530
Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases
Rieder, F., Fiocchi, C., & Rogler, G. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.09.047 · Cited by 529
Mow, W. S., Vasiliauskas, E. A., Lin, Y.-C., Fleshner, P. R., Papadakis, K. A., Taylor, K. D., Landers, C. J., Abreu-Martin, M. T., Rotter, J. I., Yang, H., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.015 · Cited by 517
Crohn's disease complicated by strictures: a systematic review
Rieder, F., Zimmermann, E. M., Remzi, F. H., & Sandborn, W. J. (2013) · Gut · doi:10.1136/gutjnl-2012-304353 · Cited by 513
Panés, J., García-Olmo, D., Van Assche, G., Colombel, J. F., Reinisch, W., Baumgart, D. C., Dignass, A., Nachury, M., Ferrante, M., Kazemi-Shirazi, L., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.12.020 · Cited by 483
Self-citationECCO-ESCP Consensus on Surgery for Crohn’s Disease
Bemelman, W. A., Warusavitarne, J., Sampietro, G. M., Serclova, Z., Zmora, O., Luglio, G., de Buck van Overstraeten, A., Burke, J. P., Buskens, C. J., Francesco, C., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx061 · Cited by 399
IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis
Hams, E., Armstrong, M. E., Barlow, J. L., Saunders, S. P., Schwartz, C., Cooke, G., Fahy, R. J., Crotty, T. B., Hirani, N., Flynn, R. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315854111 · Cited by 376
Intestinal fibrosis in IBD—a dynamic, multifactorial process
Rieder, F., & Fiocchi, C. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.31 · Cited by 343
Nutrition, IBD and Gut Microbiota: A Review
Mentella, M. C., Scaldaferri, F., Pizzoferrato, M., Gasbarrini, A., & Miggiano, G. A. D. (2020) · Nutrients · doi:10.3390/nu12040944 · Cited by 340
Bruining, D. H., Zimmermann, E. M., Loftus, E. V., Sandborn, W. J., Sauer, C. G., Strong, S. A., & Society of Abdominal Radiology Crohn’s Disease-Focused Panel (2018) · Radiology · doi:10.1148/radiol.2018171737 · Cited by 336
Bouhnik, Y., Carbonnel, F., Laharie, D., Stefanescu, C., Hébuterne, X., Abitbol, V., Nachury, M., Brixi, H., Bourreille, A., Picon, L., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-312581 · Cited by 332
Self-citationMolendijk, I., Bonsing, B. A., Roelofs, H., Peeters, K. C. M. J., Wasser, M. N. J. M., Dijkstra, G., van der Woude, C. J., Duijvestein, M., Veenendaal, R. A., Zwaginga, J.-J., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.014 · Cited by 329
Inflammation-Induced Endothelial-to-Mesenchymal Transition
Rieder, F., Kessler, S. P., West, G. A., Bhilocha, S., de la Motte, C., Sadler, T. M., Gopalan, B., Stylianou, E., & Fiocchi, C. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.07.042 · Cited by 322
Koh, A., & Bäckhed, F. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.03.005 · Cited by 309
Bettenworth, D., Bokemeyer, A., Baker, M., Mao, R., Parker, C. E., Nguyen, T., Ma, C., Panés, J., Rimola, J., Fletcher, J. G., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-318081 · Cited by 306
Wound healing and fibrosis in intestinal disease
Rieder, F., Brenmoehl, J., Leeb, S., Schölmerich, J., & Rogler, G. (2007) · Gut · doi:10.1136/gut.2006.090456 · Cited by 305
Ulcerative Colitis as A Progressive Disease: The Forgotten Evidence
Torres, J., Billioud, V., Sachar, D. B., Peyrin-Biroulet, L., & Colombel, J.-F. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22839 · Cited by 296
Self-citationYamamoto, T., Fazio, V. W., & Tekkis, P. P. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-007-0279-5 · Cited by 296
Predictors of severe Crohn's disease
Loly, C., Belaiche, J., & Louis, E. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520801957149 · Cited by 289
Flier, S. N., Tanjore, H., Kokkotou, E. G., Sugimoto, H., Zeisberg, M., & Kalluri, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.102012 · Cited by 282
Louis, E., Michel, V, Hugot, J. P., Reenaers, C., Fontaine, F., Delforge, M., El Yafi, F., Colombel, J. F., & Belaiche, J. (2003) · Gut · doi:10.1136/gut.52.4.552 · Cited by 275
Cellular and molecular mechanisms of intestinal fibrosis
Speca, S. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i28.3635 · Cited by 272
The functional significance behind expressing two IL–8 receptor types on PMN
Stillie, R., Farooq, S. M., Gordon, J. R., & Stadnyk, A. W. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0208125 · Cited by 272
Rieder, F., Bettenworth, D., Ma, C., Parker, C. E., Williamson, L. A., Nelson, S. A., van Assche, G., Di Sabatino, A., Bouhnik, Y., Stidham, R. W., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14853 · Cited by 264
Rieder, F., Latella, G., Magro, F., Yuksel, E. S., Higgins, P. D. R., Di Sabatino, A., de Bruyn, J. R., Rimola, J., Brito, J., Bettenworth, D., et al. (2016) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw055 · Cited by 261
Bettenworth, D., Gustavsson, A., Atreja, A., Lopez, R., Tysk, C., van Assche, G., & Rieder, F. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000988 · Cited by 253
Organoid Models of Human Gastrointestinal Development and Disease
Dedhia, P. H., Bertaux-Skeirik, N., Zavros, Y., & Spence, J. R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.042 · Cited by 248
Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis
Lagares, D., Santos, A., Grasberger, P. E., Liu, F., Probst, C. K., Rahimi, R. A., Sakai, N., Kuehl, T., Ryan, J., Bhola, P., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal3765 · Cited by 246
Screening and surveillance colonoscopy in chronic Crohn's colitis
Friedman, S., Rubin, P. H., Bodian, C., Goldstein, E., Harpaz, N., & Present, D. H. (2001) · Gastroenterology · doi:10.1053/gast.2001.22449 · Cited by 246
Succinate receptor mediates intestinal inflammation and fibrosis
Macias-Ceja, D. C., Ortiz-Masiá, D., Salvador, P., Gisbert-Ferrándiz, L., Hernández, C., Hausmann, M., Rogler, G., Esplugues, J. V., Hinojosa, J., Alós, R., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-018-0087-3 · Cited by 235
Bruining, D. H., Zimmermann, E. M., Loftus, E. V., Sandborn, W. J., Sauer, C. G., Strong, S. A., Al-Hawary, M., Anupindi, S., Baker, M. E., Bruining, D., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.11.274 · Cited by 234
IL-33/ST2 Axis in Organ Fibrosis
Kotsiou, O. S., Gourgoulianis, K. I., & Zarogiannis, S. G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02432 · Cited by 232
Benign and malignant colorectal strictures in ulcerative colitis.
Gumaste, V, Sachar, D. B., & Greenstein, A. J. (1992) · Gut · doi:10.1136/gut.33.7.938 · Cited by 226
Scheibe, K., Kersten, C., Schmied, A., Vieth, M., Primbs, T., Carlé, B., Knieling, F., Claussen, J., Klimowicz, A. C., Zheng, J., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.11.029 · Cited by 215
Distinct inflammatory mechanisms mediate early versus late colitis in mice
Spencer, D. M., Veldman, G. M., Banerjee, S., Willis, J., & Levine, A. D. (2002) · Gastroenterology · doi:10.1053/gast.2002.30308 · Cited by 209
Fibrosis in ulcerative colitis is directly linked to severity and chronicity of mucosal inflammation
Gordon, I. O., Agrawal, N., Willis, E., Goldblum, J. R., Lopez, R., Allende, D., Liu, X., Patil, D. Y., Yerian, L., El‐Khider, F., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14526 · Cited by 209
Johnson, L. A., Rodansky, E. S., Haak, A. J., Larsen, S. D., Neubig, R. R., & Higgins, P. D. R. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000437615.98881.31 · Cited by 197
Comparison of laparoscopic and open ileocecal resection for Crohn’s disease: a metaanalysis
Tilney, H. S., Constantinides, V. A., Heriot, A. G., Nicolaou, M., Athanasiou, T., Ziprin, P., Darzi, A. W., & Tekkis, P. P. (2006) · Surgical Endoscopy · doi:10.1007/s00464-005-0500-3 · Cited by 193
Serum Biomarkers for Inflammatory Bowel Disease
Chen, P., Zhou, G., Lin, J., Li, L., Zeng, Z., Chen, M., & Zhang, S. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00123 · Cited by 193
Scheibe, K., Backert, I., Wirtz, S., Hueber, A., Schett, G., Vieth, M., Probst, H. C., Bopp, T., Neurath, M. F., & Neufert, C. (2017) · Gut · doi:10.1136/gutjnl-2015-310374 · Cited by 188
Small, C.-L. N., Reid-Yu, S. A., McPhee, J. B., & Coombes, B. K. (2013) · Nature Communications · doi:10.1038/ncomms2957 · Cited by 185
Chen, W., Lu, C., Hirota, C., Iacucci, M., Ghosh, S., & Gui, X. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw126 · Cited by 185
Ma, C., Moran, G. W., Benchimol, E. I., Targownik, L. E., Heitman, S. J., Hubbard, J. N., Seow, C. H., Novak, K. L., Ghosh, S., Panaccione, R., et al. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.394 · Cited by 185
Mechanisms of initiation and progression of intestinal fibrosis in IBD
Latella, G., Di Gregorio, J., Flati, V., Rieder, F., & Lawrance, I. C. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2014.968863 · Cited by 184
Long-Term Results of Adipose-Derived Stem Cell Therapy for the Treatment of Crohn's Fistula
Cho, Y. B., Park, K. J., Yoon, S. N., Song, K. H., Kim, D. S., Jung, S. H., Kim, M., Jeong, H. Y., & Yu, C. S. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0199 · Cited by 176
Cellular and Molecular Mediators of Intestinal Fibrosis
Lawrance, I. C., Rogler, G., Bamias, G., Breynaert, C., Florholmen, J., Pellino, G., Reif, S., Speca, S., & Latella, G. (2015) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2014.09.008 · Cited by 174
Sponheim, J., Pollheimer, J., Olsen, T., Balogh, J., Hammarström, C. L., Loos, T., Kasprzycka, M., Sørensen, D. R., Nilsen, H. R., Küchler, A. M., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100378 · Cited by 172
Park, J., Choi, J. W., Jhun, J., Kwon, J. Y., Lee, B., Yang, C. W., Park, S., & Cho, M. (2018) · Journal of Medicinal Food · doi:10.1089/jmf.2017.3990 · Cited by 169
Telocytes in regenerative medicine
Bei, Y., Wang, F., Yang, C., & Xiao, J. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12594 · Cited by 168
EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling
Park, S.-A., Kim, M.-J., Park, S.-Y., Kim, J.-S., Lee, S., Woo, H. A., Kim, D.-K., Nam, J., & Sheen, Y. Y. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1798-6 · Cited by 164
Intestinal fibrosis in inflammatory bowel disease — Current knowledge and future perspectives
Rieder, F., & Fiocchi, C. (2008) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2008.05.009 · Cited by 162
Matrix metalloproteinases in inflammatory bowel disease: Boon or a bane?
Ravi, A., Garg, P., & Sitaraman, S. V. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20011 · Cited by 162
Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease
Lovisa, S., Genovese, G., & Danese, S. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy201 · Cited by 152
Self-citationNavaneethan, U., Lourdusamy, V., Njei, B. M., & Shen, B. (2016) · Surgical Endoscopy · doi:10.1007/s00464-016-4902-1 · Cited by 150
Fibrosis in Ulcerative Colitis: Mechanisms, Features, and Consequences of a Neglected Problem
Gordon, I. O., Agrawal, N., Goldblum, J. R., Fiocchi, C., & Rieder, F. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000080 · Cited by 143
Holvoet, T., Devriese, S., Castermans, K., Boland, S., Leysen, D. C., Vandewynckel, Y., Devisscher, L., den Bossche, L. V., Welden, S. V., Dullaers, M., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.013 · Cited by 141
Nishida, A., Hidaka, K., Kanda, T., Imaeda, H., Shioya, M., Inatomi, O., Bamba, S., Kitoh, K., Sugimoto, M., & Andoh, A. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000654 · Cited by 136
Rieder, F., Kessler, S., Sans, M., & Fiocchi, C. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00059.2012 · Cited by 135
Lenti, M. V., & Sabatino, A. D. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.10.003 · Cited by 135
Wnt Pathway-Related Gene Expression in Inflammatory Bowel Disease
You, J., Nguyen, A. V. P., Albers, G. C., Lin, F., & Holcombe, R. F. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9973-3 · Cited by 130
Yun, S., Kim, S., & Kim, E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00162 · Cited by 130
Novel mechanisms and clinical trial endpoints in intestinal fibrosis*
Wang, J., Lin, S., Brown, J. M., Wagoner, D. R. V., Fiocchi, C., & Rieder, F. (2021) · Immunological Reviews · doi:10.1111/imr.12974 · Cited by 127
Lawrance, I. C., Maxwell, L. E., & Doe, W. F. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200108000-00008 · Cited by 125
Li, C., Yang, C. W., Park, J. H., Lim, S. W., Sun, B., Jung, J., Kim, S. B., Kim, Y., Kim, J., & Bang, B. K. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00428.2002 · Cited by 123
Generation of mesenchyme free intestinal organoids from human induced pluripotent stem cells
Mithal, A., Capilla, A., Heinze, D. M., Berical, A. C., Villacorta-Martín, C., Vedaie, M., Jacob, A., Abo, K. M., Szymaniak, A. D., Peasley, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13916-6 · Cited by 123
Lakatos, P. L., Czegledi, Z., Szamosi, T., Banai, J., Dávid, G., Zsigmond, F., Pandúr, T., Erdélyi, Z., Gemela, O., Papp, J., et al. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.3504 · Cited by 113
Wilkens, R., Hagemann-Madsen, R. H., Peters, D. A., Nielsen, A. H., Nørager, C. B., Glerup, H., & Krogh, K. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx111 · Cited by 113
Fibrostenotic strictures in Crohn’s disease
Yoo, J. H., Holubar, S. D., & Rieder, F. (2020) · Intestinal Research · doi:10.5217/ir.2019.09148 · Cited by 112
A loss of telocytes accompanies fibrotic remodelling of the colonic wall in ulcerative colitis
Manetti, M., Rosa, I., Messerini, L., & Ibba‐Manneschi, L. (2014) · Italian Journal of Anatomy and Embryology · doi:10.36253/ijae-2474 · Cited by 111
Comparison of Conventional and Nonconventional Strictureplasties in Crohn’s Disease
Campbell, L., Ambe, R., Weaver, J. C., Marcus, S. M., & Cagir, B. (2012) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0b013e31824f875a · Cited by 111
Pathogenesis of fibrostenosing Crohn's disease
Li, J., Mao, R., Kurada, S. V., Wang, J., Lin, S., Chandra, J., & Rieder, F. (2019) · Translational research · doi:10.1016/j.trsl.2019.03.005 · Cited by 111
The role of interleukin 17 in Crohn’s disease-associated intestinal fibrosis
Biancheri, P., Pender, S. L. F., Ammoscato, F., Giuffrida, P., Sampietro, G. M., Ardizzone, S., Ghanbari, A., Curciarello, R., Pasini, A., Monteleone, G., et al. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-13 · Cited by 110
Inflammation-independent TL1A-mediated intestinal fibrosis is dependent on the gut microbiome
Jacob, N., Jacobs, J. P., Kumagai, K., Ha, C. W. Y., Kanazawa, Y., Lagishetty, V., Altmayer, K., Hamill, A. M., Von Arx, A., Sartor, R. B., et al. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0055-y · Cited by 102
Novel PPARγ Modulator GED-0507-34 Levo Ameliorates Inflammation-driven Intestinal Fibrosis
Speca, S., Rousseaux, C., Dubuquoy, C., Rieder, F., Vetuschi, A., Sferra, R., Giusti, I., Bertin, B., Dubuquoy, L., Gaudio, E., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000618 · Cited by 101
Lo, B. C., Gold, M. J., Hughes, M. R., Antignano, F., Valdez, Y., Zaph, C., Harder, K. W., & McNagny, K. M. (2016) · Science Immunology · doi:10.1126/sciimmunol.aaf8864 · Cited by 101
The extracellular matrix in IBD: a dynamic mediator of inflammation
Petrey, A. C., & de la Motte, C. A. (2017) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000368 · Cited by 100
Sun, Y., Zhang, Y., Ke, X.-J., Wu, X., Chen, Z., & Chi, P. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.01.027 · Cited by 94
Intestinal Stricture in Crohn's Disease
Chang, C., Wong, J., Tung, C., Shih, I., Wang, H., & Wei, S. (2015) · Intestinal Research · doi:10.5217/ir.2015.13.1.19 · Cited by 93
Flagellin-mediated activation of IL-33-ST2 signaling by a pathobiont promotes intestinal fibrosis
Imai, J., Kitamoto, S., Sugihara, K., Nagao-Kitamoto, H., Hayashi, A., Morhardt, T. L., Kuffa, P., Higgins, P. D. R., Barnich, N., & Kamada, N. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0138-4 · Cited by 91
Role of endoscopy in predicting the disease course in inflammatory bowel disease
Allez, M., & Lémann, M. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i21.2626 · Cited by 89
Development of Fibrosis in Acute and Longstanding Ulcerative Colitis
de Bruyn, J. R., Meijer, S. L., Wildenberg, M. E., Bemelman, W. A., van den Brink, G. R., & D’Haens, G. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv133 · Cited by 89
Mortensen, J. H., Godskesen, L. E., Jensen, M. D., van Haaften, W. T., Klinge, L. G., Olinga, P., Dijkstra, G. D. H., Kjeldsen, J., Karsdal, M. A., Bay‐Jensen, A., et al. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv123 · Cited by 87
Sadler, T. M., Bhasin, J., Xu, Y., Barnholz-Sloan, J., Chen, Y., Ting, A. H., & Stylianou, E. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0193-6 · Cited by 87
Intestinal Organoids: New Frontiers in the Study of Intestinal Disease and Physiology
Wallach, T. E., & Bayrer, J. R. (2016) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001411 · Cited by 86
Eosinophil depletion suppresses radiation-induced small intestinal fibrosis
Takemura, N., Kurashima, Y., Mori, Y., Okada, K., Ogino, T., Osawa, H., Matsuno, H., Lamichhane, A., Kaneto, S., Park, E. J., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan0333 · Cited by 85
Zhao, Z., Cheng, W., Qu, W., Shao, G., & Liu, S. (2020) · ACS Omega · doi:10.1021/acsomega.9b03906 · Cited by 84
Michelassi, F., Taschieri, A. M., Tonelli, F., Sasaki, I., Poggioli, G., Fazio, V. W., Upadhyay, G. A., Hurst, R. D., Sampietro, G. M., Fazi, M., et al. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-006-0804-y · Cited by 82
IL-17A Promotes Initiation and Development of Intestinal Fibrosis Through EMT
Zhang, H., Zhang, Y.-N., Zhou, H., Guan, L., Li, Y., & Sun, M. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5234-x · Cited by 81
Regulation of Migration of Human Colonic Myofibroblasts
Leeb, S. N., Vogl, D., Falk, W., et al. (2002) · Growth Factors · doi:10.1080/08977190290031941 · Cited by 80
TRP channels in cardiac and intestinal fibrosis
Inoue, R., Kurahara, L. H., & Hiraishi, K. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.11.002 · Cited by 80
Ungaro, F., Massimino, L., D’Alessio, S., & Danese, S. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640619876787 · Cited by 79
Self-citationGordon, I., Bettenworth, D., Bokemeyer, A., Srivastava, A., Rosty, C., Hertogh, G., Robert, M., Valasek, M. A., Mao, R., Kurada, S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.08.033 · Cited by 78
Yamagata, M., Mikami, T., Tsuruta, T., Yokoyama, K., Sada, M., Kobayashi, K., Katsumata, T., Koizumi, W., Saigenji, K., & Okayasu, I. (2011) · Digestion · doi:10.1159/000320773 · Cited by 77
Masterson, J. C., Capocelli, K. E., Hosford, L., Biette, K. A., McNamee, E. N., de Zoeten, E. F., Harris, R. F., Fernando, S. D., Jedlicka, P., Protheroe, C. A., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000512 · Cited by 75
Predictors of fibrostenotic Crohnʼs disease
Rieder, F., Lawrance, I. C., Leite, A. Z. D. A., & Sans, M. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21627 · Cited by 74
Truffi, M., Sorrentino, L., Monieri, M., Fociani, P., Mazzucchelli, S., Bonzini, M., Zerbi, P., Sampietro, G. M., Sabatino, A. D., & Corsi, F. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izx008 · Cited by 74
Abe, Y., Murano, M., Murano, N., Morita, E., Inoue, T., Kawakami, K., Ishida, K., Kuramoto, T., Kakimoto, K., Okada, T., et al. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1879-4 · Cited by 70
Li, G., Ren, J., Hu, Q., Deng, Y., Chen, G., Guo, K., Li, R., Li, Y., Wu, L., Wang, G., et al. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.08.002 · Cited by 69
Pathogenesis of ulcerative colitis.
WARREN, S., & SOMMERS, S. C. (1949) · PubMed · Cited by 67
Bemelman, W. A., collaborators, S.-E., Adamina, M., Buskens, C. J., D’Hoore, A. J. L., Kotze, P. G., Öresland, T., Panis, Y. H., Samprieto, G., Spinelli, A., et al. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy056 · Cited by 66
Microbial Regulation of Enteric Eosinophils and Its Impact on Tissue Remodeling and Th2 Immunity
Jiménez‐Saiz, R., Anipindi, V. C., Galipeau, H. J., Ellenbogen, Y., Chaudhary, R., Koenig, J. F. E., Gordon, M. E., Walker, T. D., Mandur, T. S., Abed, S., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00155 · Cited by 66
Natural history and complications of IBD
Vatn, M. H. (2009) · Current Gastroenterology Reports · doi:10.1007/s11894-009-0073-8 · Cited by 65
Cui, Y., Zhang, M., Leng, C., Blokzijl, T., Jansen, B. H., Dijkstra, G. D. H., & Faber, K. N. (2020) · Cells · doi:10.3390/cells9030775 · Cited by 65
van Haaften, W. T., Mortensen, J. H., Karsdal, M. A., Bay‐Jensen, A., Dijkstra, G. D. H., & Olinga, P. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14092 · Cited by 63
Thermodynamic Aspects and Reprogramming Cellular Energy Metabolism during the Fibrosis Process
Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122537 · Cited by 63
Yoo, J. H., Ho, S., Tran, D. H., Cheng, M., Bakirtzi, K., Kubota, Y., Ichikawa, R., Su, B., Tran, D., Hing, T. C., et al. (2014) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2014.08.001 · Cited by 61
Clinical course of Crohn’s disease first diagnosed at surgery for acute abdomen
Latella, G., Cocco, A., Angelucci, E., Viscido, A., Bacci, S., Necozione, S., & Caprilli, R. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2008.09.010 · Cited by 60
Allocca, M., Fiorino, G., Bonifacio, C., Peyrin‐Biroulet, L., & Danese, S. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.04.025 · Cited by 60
Self-citation黒田, 直., Masuya, M., Tawara, I., Tsuboi, J., Yoneda, M., Nishikawa, K., Kageyama, Y., Hachiya, K., Ohishi, K., Miwa, H., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45012-6 · Cited by 60
Ellermann, M., Gharaibeh, R. Z., Fulbright, L. E., Dogan, B., Moore, L. N., Broberg, C. A., Lopez, L. R., Rothemich, A., Herzog, J., Rogala, A. R., et al. (2019) · Infection and Immunity · doi:10.1128/iai.00587-19 · Cited by 60
Zhao, S., Dejanovic, D., Yao, P., Bhilocha, S., Sadler, T., Schirbel, A., West, G., Doyon, G., Lopez, R., Mao, R., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0259-9 · Cited by 59
Autocrine Fibronectin-Induced Migration of Human Colonic Fibroblasts
Leeb, S. N., Vogl, D., Grossmann, J., Falk, W., Schölmerich, J., Rogler, G., & Gelbmann, C. M. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04044.x · Cited by 58
Kurahara, L. H., Hiraishi, K., Hu, Y., Koga, K., Onitsuka, M., Doi, M., Aoyagi, K., Takedatsu, H., Kojima, D., Fujihara, Y., et al. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.12.005 · Cited by 58
Systematic review: medical therapy for fibrostenosing Crohn’s disease
Lu, C., Baraty, B., Robertson, H. L., Filyk, A., Shen, H., Fung, T. S., Novak, K. L., Ma, C., Panaccione, R., Achkar, J., et al. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15750 · Cited by 56
Jin, W., Ni, H., Dai, Y., Wang, H., Lu, T., Wu, J., Jiang, J., & Liang, W. (2010) · Mediators of Inflammation · doi:10.1155/2010/502564 · Cited by 54
Kim, M., Park, S.-A., Kim, C. H., Park, S.-Y., Kim, J.-S., Kim, D., Nam, J., & Sheen, Y. Y. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000438651 · Cited by 54
Ortiz‐Masiá, D., Salvador, P., Macias-Ceja, D. C., Gisbert-Ferrándiz, L., Esplugues, J. V., Manyé, J., Alós, R., Navarro-Vicente, F., Mamie, C., Scharl, M. M., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz134 · Cited by 53
ELR-CXC Chemokine Receptor Antagonism Targets Inflammatory Responses at Multiple Levels
Zhao, X., Town, J. R., Li, F., Zhang, X., Cockcroft, D. W., & Gordon, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800551 · Cited by 52
Sun, Y., Zhang, Y., & Chi, P. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9423 · Cited by 50
Prados, M. E., García‐Martín, A., Unciti-Broceta, J. D., Palomares, B., Collado, J. A., Minassi, A., Calzado, M. A., Appendino, G., & Muñóz, E. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0497-0 · Cited by 50
Matrix metalloproteinases as profibrotic factors in terminal ileum in Crohnʼs disease
Warnaar, N., Hofker, S. H., Maathuis, M. H. J., Niesing, J., Bruggink, A. H., Dijkstra, G. D. H., Ploeg, R. J., & Schuurs, T. A. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000231568.43065.ed · Cited by 49
Walana, W., Ye, Y., Li, M., Wang, J., Wang, B., Cheng, J., Gordon, J., & Fang, L. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.008 · Cited by 49
AXL Is a Potential Target for the Treatment of Intestinal Fibrosis
Steiner, C. A., Rodansky, E. S., Johnson, L. A., Berinstein, J. A., Cushing, K. C., Huang, S., Spence, J. R., & Higgins, P. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa169 · Cited by 49
Guan, Y., Tan, Y., Liu, W., Yang, J., Wang, D., Pan, D., Sun, Y., & Zheng, C. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4710-z · Cited by 48
Burke, J. P., Watson, R. W. G., Murphy, M., Docherty, N. G., Coffey, J. C., & O’Connell, P. R. (2009) · British journal of surgery · doi:10.1002/bjs.6577 · Cited by 47
Meier, R., Lutz, C., Cosín‐Roger, J., Fagagnini, S., Bollmann, G., Hünerwadel, A., Mamie, C., Lang, S., Tchouboukov, A., Weber, F. E., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000716 · Cited by 47
Allocca, M., Bonifacio, C., Fiorino, G., Spinelli, A., Furfaro, F., Balzarini, L., Bonovas, S., & Danese, S. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.03.012 · Cited by 47
Self-citationDifferentiation of fibrotic and inflammatory component of Crohn’s disease-associated strictures
Rimola, J., & Capozzi, N. (2020) · Intestinal Research · doi:10.5217/ir.2020.00015 · Cited by 47
Intestinal Activation of pH-Sensing Receptor OGR1 [GPR68] Contributes to Fibrogenesis
Hutter, S., van Haaften, W. T., Hünerwadel, A., Baebler, K., Herfarth, N., Raselli, T., Mamie, C., Misselwitz, B., Rogler, G., Weder, B., et al. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy118 · Cited by 46
Burke, J. P., Cunningham, M. F., Sweeney, C., Docherty, N. G., & O’Connell, P. R. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21543 · Cited by 44
Telocytes in Chronic Inflammatory and Fibrotic Diseases
Ibba‐Manneschi, L., Rosa, I., & Manetti, M. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-1061-3_4 · Cited by 42
Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn’s Disease
Danese, S., Bonovas, S., Lopez, A., Fiorino, G., Sandborn, W. J., Rubin, D. T., Kamm, M. A., Colombel, J., Sands, B. E., Vermeire, S., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.03.032 · Cited by 42
Self-citationEW‐7197 prevents ulcerative colitis‐associated fibrosis and inflammation
Binabaj, M. M., Asgharzadeh, F., Avan, A., Rahmani, F., Soleimani, A., Parizadeh, M. R., Ferns, G. A., Ryzhikov, M., Khazaei, M., & Hassanian, S. M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27823 · Cited by 42
Controversial Contribution of Th17/IL-17 Toward the Immune Response in Intestinal Fibrosis
Latella, G., & Viscido, A. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06161-1 · Cited by 42
Jun, Y. K., Kwon, S. H., Yoon, H. T., Park, H., Soh, H., Lee, H. J., Im, J. P., Kim, J. S., Kim, J. W., & Koh, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-76880-y · Cited by 42
Endoscopic balloon dilation of Crohn’s disease strictures-safety, efficacy and clinical impact
Lopes, S., Rodrigues‐Pinto, E., Andrade, P., Afonso, J., Baron, T. H., Magro, F., & Macedo, G. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i41.7397 · Cited by 40
Onozato, D., Akagawa, T., Kida, Y., Ogawa, I., Hashita, T., Iwao, T., & Matsunaga, T. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00088 · Cited by 40
Decellularized Human Gut as a Natural 3D Platform for Research in Intestinal Fibrosis
Giuffrida, P., Curti, M., Al‐Akkad, W., Biel, C., Crowley, C., Frenguelli, L., Telese, A., Hall, A. R., Tamburrino, D., Spoletini, G., et al. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz115 · Cited by 37
Cadherin-11 Is a Regulator of Intestinal Fibrosis
Franzè, E., Monteleone, I., Laudisi, F., Rizzo, A., Dinallo, V., Fusco, D. D., Colantoni, A., Ortenzi, A., Giuffrida, P., Carlo, S. D., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz147 · Cited by 37
Modeling Progressive Fibrosis with Pluripotent Stem Cells Identifies an Anti-fibrotic Small Molecule
Vijayaraj, P., Minasyan, A., Durra, A., Karumbayaram, S., Mehrabi, M., Aros, C. J., Ahadome, S. D., Shia, D. W., Chung, K., Sandlin, J. M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.019 · Cited by 35
Emergence of Fibrocytes Showing Morphological Changes in the Inflamed Colonic Mucosa
Uehara, H., Nakagawa, T., Katsuno, T., Satô, T., Isono, A., Noguchi, Y., & Saitō, Y. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0730-7 · Cited by 30
Inhibition of plasminogen activator inhibitor-1 attenuates against intestinal fibrosis in mice
Imai, J., Yahata, T., Ichikawa, H., Ibrahim, A. A., Yazawa, M., Sumiyoshi, H., Inagaki, Y., Matsushima, M., Suzuki, T., Mine, T., et al. (2020) · Intestinal Research · doi:10.5217/ir.2019.00037 · Cited by 27
Pirfenidone inhibits the proliferation of fibroblasts from patients with active Crohn’s disease
Kadir, S.-I., Kragstrup, T. W., Dige, A. K., Jensen, S. K., Dahlerup, J. F., & Kelsen, J. (2016) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2016.1185146 · Cited by 26
Guan, Q., Weiss, C. R., Wang, S., Qing, G., Yang, X., Warrington, R., Bernstein, C. N., & Peng, Z. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy142 · Cited by 26
Incidence of and Risk Factors for Colorectal Strictures in Ulcerative Colitis: A Multicenter Study
Laurain, P.-A., Guillo, L., D’Amico, F., Netter, P., Danese, S., Baumann, C., Luc, A., Clerc‐Urmès, I., Sofos, S., & Peyrin‐Biroulet, L. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.01.028 · Cited by 24
Self-citationNovel biomarkers of fibrosis in Crohn’s disease
Pellino, G., Pallante, P., & Selvaggi, F. (2016) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v7.i3.266 · Cited by 23
Bian, H., Zhou, Y., Yu, B., Shang, D., Liu, F., Li, B., & Qi, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6826 · Cited by 19
Rationale for IL-36 receptor antibodies in ulcerative colitis
Neufert, C. F., Neurath, M. F., & Atreya, R. N. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1695775 · Cited by 19
Role of non‐inflammatory factors in intestinal fibrosis
Zhao, J., Ling, F. M., Li, J. R., Chen, Y. D., Huang, L., & Zhu, L. (2020) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12883 · Cited by 19
Chokr, D., Cornu, M., Neut, C., Bortolus, C., Charlet, R., Desreumaux, P., Speca, S., & Sendid, B. (2021) · Gut Pathogens · doi:10.1186/s13099-021-00401-z · Cited by 19
Decoy receptor springs to life and eases fibrosis
MacDonald, T. T. (2006) · Nature Medicine · doi:10.1038/nm0106-13 · Cited by 17
da Cunha, V. P., Preisser, T. M., Santana, M. P., Machado, D. C. C., Pereira, V. B., & Miyoshi, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-77276-8 · Cited by 15
Treatment of inflammatory bowel diseases: To heal the wound or to heal the sick?
Caprilli, R., Latella, G., & Frieri, G. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.02.009 · Cited by 13
Resolving intestinal fibrosis through regenerative medicine
Schwab, R., Lim, R., & Goldberg, R. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.09.011 · Cited by 11
Kurahara, L. H., Hiraishi, K., Sumiyoshi, M., Doi, M., Hu, Y., Aoyagi, K., Jian, Y., & Inoue, R. (2016) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.52.78 · Cited by 9
Kim, S. Y., Park, M.-J., Kwon, J.-E., Choi, S., Seo, H.-B., Jung, K. A., Choi, J., Baek, J.-A., Lee, H. H., Lee, B., et al. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.11.001 · Cited by 7
Pathogenesis of Crohn's Disease- and Ulcerative Colitis-Related Strictures
Ko, J. Z.-H., Abraham, J. P., & Shih, D. Q. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811388-2.00003-8 · Cited by 4
Clinical, Cellular and Serologic Biomarkers of Intestinal Fibrosis
Sabatino, A. D., & Giuffrida, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-90578-5_12 · Cited by 2
Epidemiology and Natural History of Fibrostenosing Inflammatory Bowel Disease
Ng, W. K., & Ng, S. C. (2018) · Springer eBooks · doi:10.1007/978-3-319-90578-5_2 · Cited by 1
Cited by
Pathophysiology of Inflammatory Bowel Disease: Innate Immune System
Saez, A., Herrero-Fernandez, B., Gomez-Bris, R., Sánchez-Martinez, H., & Gonzalez-Granado, J. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021526 · Cited by 580
ECM formation and degradation during fibrosis, repair, and regeneration
Mayorca-Guiliani, A. E., Leeming, D. J., Henriksen, K., Mortensen, J. H., Nielsen, S. H., Anstee, Q. M., Sanyal, A. J., Karsdal, M. A., & Schuppan, D. (2025) · npj Metabolic Health and Disease · doi:10.1038/s44324-025-00063-4 · Cited by 176
Modelling and targeting mechanical forces in organ fibrosis
Mascharak, S., L. Guo, J., Griffin, M., E. Berry, C., C. Wan, D., & T. Longaker, M. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00144-3 · Cited by 59
“Similar processes of ECM compositional change and connective tissue thickening have been implicated in the pathogenesis of intestinal fibrosis, including similar feedforward loops for myofibroblasts 30,31 .”
Bar, S., Hilsabeck, T. A. U., Pattavina, B., López-Domínguez, J. A., Basisty, N., Bons, J., Watson, M., Schilling, B., Campisi, J., Kapahi, P., et al. (2025) · Aging · doi:10.18632/aging.206224 · Cited by 3
Metadata
- Authors
- D’Alessio, S., Ungaro, F., Noviello, D., Lovisa, S., Peyrin-Biroulet, L., & Danese, S.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2021-12-07
- Volume
- 19
- Issue
- 3
- Pages
- 169-184
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W4200510809
- Cited by
- 253
- References
- 178
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.